Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis
Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effecacy and safety of dialysis centers
switching its dialysis patients from using recombinant human erythropoietin injection (CHO
Cell) (ESPO) to Pegol-Sihematide injection on hemoglobin levels and other parameters.